227 related articles for article (PubMed ID: 25609482)
1. [Update on genetic predisposition to prostate cancer].
Cussenot O; Cancel-Tassin G
Bull Cancer; 2015 Jan; 102(1):53-6. PubMed ID: 25609482
[TBL] [Abstract][Full Text] [Related]
2. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
[TBL] [Abstract][Full Text] [Related]
3. Screening for familial and hereditary prostate cancer.
Lynch HT; Kosoko-Lasaki O; Leslie SW; Rendell M; Shaw T; Snyder C; D'Amico AV; Buxbaum S; Isaacs WB; Loeb S; Moul JW; Powell I
Int J Cancer; 2016 Jun; 138(11):2579-91. PubMed ID: 26638190
[TBL] [Abstract][Full Text] [Related]
4. Familial prostate cancer.
Giri VN; Beebe-Dimmer JL
Semin Oncol; 2016 Oct; 43(5):560-565. PubMed ID: 27899188
[TBL] [Abstract][Full Text] [Related]
5. HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
Laitinen VH; Wahlfors T; Saaristo L; Rantapero T; Pelttari LM; Kilpivaara O; Laasanen SL; Kallioniemi A; Nevanlinna H; Aaltonen L; Vessella RL; Auvinen A; Visakorpi T; Tammela TL; Schleutker J
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):452-60. PubMed ID: 23292082
[TBL] [Abstract][Full Text] [Related]
6. Perspective: prostate cancer susceptibility genes.
Simard J; Dumont M; Soucy P; Labrie F
Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
[TBL] [Abstract][Full Text] [Related]
7. Italian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genes.
Cortesi L; Turchetti D; Bertoni C; Zanocco-Marani T; Vinceti M; Silvestri C; Federico M; Silingardi V; Ferrari S
Eur J Hum Genet; 2003 Mar; 11(3):210-4. PubMed ID: 12673274
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
9. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 have a limited role in familial prostate cancer.
Sinclair CS; Berry R; Schaid D; Thibodeau SN; Couch FJ
Cancer Res; 2000 Mar; 60(5):1371-5. PubMed ID: 10728701
[TBL] [Abstract][Full Text] [Related]
11. Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer.
Tischkowitz M; Eeles R;
Lancet; 2003 Jul; 362(9377):80; author reply 80. PubMed ID: 12853213
[No Abstract] [Full Text] [Related]
12. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
Vazina A; Baniel J; Yaacobi Y; Shtriker A; Engelstein D; Leibovitz I; Zehavi M; Sidi AA; Ramon Y; Tischler T; Livne PM; Friedman E
Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
[TBL] [Abstract][Full Text] [Related]
13. Genitourinary cancer predisposition syndromes.
Gallagher DJ; Feifer A; Coleman JA
Hematol Oncol Clin North Am; 2010 Oct; 24(5):861-83. PubMed ID: 20816578
[TBL] [Abstract][Full Text] [Related]
14. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.
Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB
Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998
[TBL] [Abstract][Full Text] [Related]
15. Young-age prostate cancer.
Hussein S; Satturwar S; Van der Kwast T
J Clin Pathol; 2015 Jul; 68(7):511-5. PubMed ID: 25837493
[TBL] [Abstract][Full Text] [Related]
16. Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic.
Horsburgh S; Matthew A; Bristow R; Trachtenberg J
Prostate; 2005 Oct; 65(2):124-9. PubMed ID: 15880530
[TBL] [Abstract][Full Text] [Related]
17. BRCA2 mutation in a family with hereditary prostate cancer.
Grönberg H; Ahman AK; Emanuelsson M; Bergh A; Damber JE; Borg A
Genes Chromosomes Cancer; 2001 Mar; 30(3):299-301. PubMed ID: 11170288
[TBL] [Abstract][Full Text] [Related]
18. Cancer risks for men with BRCA1/2 mutations.
Mahon SM
Oncol Nurs Forum; 2014 Jan; 41(1):99-101. PubMed ID: 24368245
[No Abstract] [Full Text] [Related]
19. Genetic testing by cancer site: ovary.
Weissman SM; Weiss SM; Newlin AC
Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
[TBL] [Abstract][Full Text] [Related]
20. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
